CRABP2 Promotes Lung Adenocarcinoma Through Retinoic Acid Pathway-Mediated NF-κB Activation
Frontiers in Bioscience-Landmark · 27.07.2026 · 31 (7)
DOI: 10.31083/fbl51377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 27.07.2026. Verfasst von XiRui Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery II, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, 650118 …. Hauptthemen laut MEDLINE: NF-kappa B, Tretinoin, Lung Neoplasms, Receptors, Retinoic Acid. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Clinical Research Project of the "Kunyi Leading Research" Program of Kunming Medical University, Joint Program of Applied Basic Research of Yunnan Provincial Department of Science and Technology - Kunming Medical University, Key Project of the Joint Special Program of Kunming Medical University.
Abstract (Originalsprache)
Background:Lung adenocarcinoma (LUAD) is the most common subtype of non-small cell lung cancer and remains a major cause of cancer-related mortality. Despite advances in targeted therapies, tumor heterogeneity and acquired resistance frequently undermine clinical outcomes. This study aimed to identify novel oncogenic drivers and underlying mechanisms in LUAD.Methods:We examined cellular retinoic acid-binding protein 2 (CRABP2) expression in human LUAD specimens and evaluated its functional role through in vitro assays (cell proliferation, migration, invasion, and apoptosis) and in vivo xenograft tumor growth. Mechanistic exploration involved RNA sequencing, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, and immunoblotting for the nuclear factor kappa B (NF-κB) signaling components, along with rescue experiments to dissect the pathway dependency.Results:CRABP2 was identified as a candidate oncogene in LUAD. Functional assays confirmed that CRABP2 promoted proliferation, migration, and invasion, suppressed apoptosis, and accelerated xenograft tumor growth. Mechanistically, CRABP2 potentiated retinoic acid (RA) signaling and activated the NF-κB pathway, as evidenced by enhanced inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) phosphorylation, subsequent NF-κB inhibitor alpha (IκBα) phosphorylation, and nuclear translocation of total and phosphorylated p65. Rescue experiments revealed that CRABP2‑induced NF-κB activation is RA-dependent and that this activation mediates the oncogenic effects of CRABP2.Conclusions:Our findings establish a CRABP2/RA/NF‑κB axis that drives LUAD progression, highlighting this pathway as a potential therapeutic target for intervention in LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery II, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, 650118 Kunming, Yunnan, China.
- Department of Nuclear Medicine, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, 650118 Kunming, Yunnan, China.
Förderung
- Key Clinical Research Project of the "Kunyi Leading Research" Program of Kunming Medical University
- Joint Program of Applied Basic Research of Yunnan Provincial Department of Science and Technology - Kunming Medical University
- Key Project of the Joint Special Program of Kunming Medical University
- Key Clinical Research Project of the “Kunyi Leading Research” Program of Kunming Medical University
Zitieren
APA
Zhu, X., Fan, B., Lei, Q., Xin, C., Li, X., Ma, Z., Xie, S., Shang, J., Li, Z., Liu, C., & Wang, W. (2026). CRABP2 Promotes Lung Adenocarcinoma Through Retinoic Acid Pathway-Mediated NF-κB Activation. Frontiers in Bioscience-Landmark, 31(7). https://doi.org/10.31083/fbl51377
Vancouver
Zhu X, Fan B, Lei Q, Xin C, Li X, Ma Z, et al. CRABP2 Promotes Lung Adenocarcinoma Through Retinoic Acid Pathway-Mediated NF-κB Activation. Frontiers in Bioscience-Landmark. 2026;31(7). doi:10.31083/fbl51377
BibTeX
@article{Zhu2026,
author = {Zhu, XiRui and Fan, BiaoFeng and Lei, Qing and Xin, ChenJun and Li, XuanCheng and Ma, ZhongRui and Xie, SiQi and Shang, JianLiang and Li, ZuYang and Liu, Chao and Wang, WeiWei},
title = {CRABP2 Promotes Lung Adenocarcinoma Through Retinoic Acid Pathway-Mediated NF-κB Activation},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {7},
doi = {10.31083/fbl51377}
}
EUVIMED